The Partnering Agreements with Genmab report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. Read the full story
Tag Archive | "Genmab"
OMT joins in a pharma alliance with Genmab
Posted on 02 October 2014
Open Monoclonal Technology announced an pharma alliance with Genmab. Read the full story
Genmab: Partnering activity 2009-2014
Posted on 29 September 2014
Genmab, a top big biotech company, headquartered in Denmark is one of the leaders today in the human antibody therapeutics market for cancer treatment. Read the full story
Genmab: Rapidly progressing in the field of antibodies
Posted on 19 September 2014
Genmab is an internationally recognised biotechnology company developing human antibody therapeutics primarily for cancer. Read the full story
Genmab has raised $183 million in private financing
Posted on 27 January 2014
Genmab has raised gross proceeds of DKK 998 million ($183 million) following pricing of its previously announced private placement financing. Read the full story
Genmab receives $1 million milestone in biotech deals with Janssen
Posted on 27 August 2013
Genmab has reached another milestone in its DuoBody technology platform biotech deals with Janssen Biotech and its affiliates, triggering a $1 million payment. Read the full story
Genmab big biotech deals with ADC Therapeutics for oncology drug development
Posted on 17 June 2013
Genmab, a big biotech company, and ADC Therapeutics have entered biotech deals for the co-development of a new antibody-drug conjugate product combining Genmab’s HuMax-TAC antibody and ADC Therapeutics’ PBD-based warhead and linker technology. Read the full story
Janssen inks biotech partnering with Genmab for antibody development
Posted on 16 July 2012
Genmab and Janssen Biotech, both big biotech companies has agreed to collaborate in biotech partnering agreement to create and develop antibodies using its DuoBody technology platform and will receive an upfront payment of $3.5 million.
